Efficacy of DPP ‐4 inhibitors, GLP‐1 analogues, and SGLT2 inhibitors as add‐ons to metformin monotherapy in T2DM patients: A model‐based meta‐analysis (149/150)

ConclusionsOnce weekly exenatide, liraglutide, and dulaglutide provided better hypoglycaemic effects among the antidiabetic drugs analysed. Long ‐acting GLP‐1r appears to be more useful for T2DM patients inadequately controlled with metformin monotherapy.

Source: British Journal of Clinical Pharmacology - November 5, 2018 Category: Drugs & Pharmacology Authors: Hiroyuki Inoue, Yoko Tamaki, Yushi Kashihara, Shota Muraki, Makoto Kakara, Takeshi Hirota, Ichiro Ieiri Tags: ORIGINAL ARTICLE Source Type: research